Chemometec AS 

€40.28
0
-€0.04-0.1% Friday 19:31

Statistics

Day High
41.52
Day Low
40.28
52W High
105.5
52W Low
36.84
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4FebExpected
Q4 2025
0.72
0.77
0.83
0.89
Expected EPS
0.8879016187200001
Actual EPS
0.7177647816

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CHY.STU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Thermo Fisher Scientific
TMO
Mkt Cap182.57B
Thermo Fisher Scientific offers a wide range of analytical instruments and laboratory equipment, competing in the cell analysis market similar to ChemoMetec.
Danaher
DHR
Mkt Cap135.26B
Danaher Corporation, through its subsidiaries, provides various biotech and life sciences products, including cell imaging and analysis systems that compete with ChemoMetec's offerings.
Bio-Rad Laboratories
BIO
Mkt Cap7.56B
Bio-Rad Laboratories, Inc. produces and supplies systems for the life science research and clinical diagnostics markets, including cell counting and imaging products.
Agilon Health
AGL
Mkt Cap178.35M
Agilent Technologies provides instruments, services, and consumables for laboratories worldwide, including cell analysis technologies that rival ChemoMetec's.
Illumina
ILMN
Mkt Cap19.48B
Illumina, Inc. offers sequencing and array-based solutions for genetic analysis, which competes with ChemoMetec's cell analysis technologies in the genomics and research sectors.
Repligen
RGEN
Mkt Cap6.59B
Repligen Corporation supplies bioprocessing technologies and systems that are used in the production of biological drugs, competing indirectly by offering complementary technologies for cell analysis.
Bio-Techne
TECH
Mkt Cap8.31B
Bio-Techne Corporation develops, manufactures, and sells life sciences reagents, instruments, and services for research, including cell and gene analysis products that compete with ChemoMetec.
Qiagen NV
QGEN
Mkt Cap8.46B
Qiagen N.V. provides sample to insight solutions that transform biological materials into valuable molecular insights, including cell analysis technologies that compete with ChemoMetec's offerings.

About

ChemoMetec A/S engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally. The company offers its solutions in the areas of cell and gene therapy, cancer and stem cell research, and development and manufacturing of pharmaceuticals, as well as production and quality control of animal semen, milk, and beer. Its products include NucleoCounter NC-3000, an advanced image cytometer; NucleoCounter NC-250, an automated cell analyzer; NucleoCounter NC-202, a consistent cell counter; NucleoCounter NC-200, an automated cell counter that provides solution for cell counting and cell viability determination; NucleoCounter SP-100, an automated sperm cell counter for use in animal reproduction; and XcytoMatic 40, a cell density and viability analyzer. In addition, the company provides consumables comprising cassettes, reagents, lysis, and slides; accessories, which include cables, power supplies, software, and labware products, as well as service and validation plans and training. Further, it develops XcytoMatic 30 cell counter and Xcyto 5, a versatile cell analyzer. ChemoMetec A/S was incorporated in 1997 and is headquartered in Allerød, Denmark.
Show more...
CEO
Mr. Martin Helbo Behrens
Employees
172
Country
Germany
ISIN
DK0060055861

Listings

0 Comments

Share your thoughts

FAQ

What is Chemometec AS stock price today?
The current price of CHY.STU is €40.28 EUR — it has decreased by -0.1% in the past 24 hours. Watch Chemometec AS stock price performance more closely on the chart.
What is Chemometec AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Chemometec AS stocks are traded under the ticker CHY.STU.
Is Chemometec AS stock price growing?
CHY.STU stock has fallen by -2.23% compared to the previous week, the month change is a -24.5% fall, over the last year Chemometec AS has showed a -34.4% decrease.
When is the next Chemometec AS earnings date?
Chemometec AS is going to release the next earnings report on September 10, 2026.
What were Chemometec AS earnings last quarter?
CHY.STU earnings for the last quarter are 0.72 EUR per share, whereas the estimation was 0.89 EUR resulting in a -19.16% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Chemometec AS have?
As of April 12, 2026, the company has 172 employees.
In which sector is Chemometec AS located?
Chemometec AS operates in the Health & Wellness sector.
When did Chemometec AS complete a stock split?
Chemometec AS has not had any recent stock splits.
Where is Chemometec AS headquartered?
Chemometec AS is headquartered in Allerød, Germany.